## IVZ: Invesco Ltd - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 1.9% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($25.44)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. A Look Into Invesco Inc's Price Over Earnings**
- Source: Benzinga | 20251218T210804 | Neutral | Relevance: 100%
- Invesco Inc. (NYSE: IVZ) has seen significant stock increases recently, prompting an examination of its price-to-earnings (P/E) ratio. Currently, Invesco's P/E ratio of 17.96 is lower than the Capital Markets industry aggregate of 61.02. While a lower P/E ratio can suggest undervaluation or potentially lower future growth expectations, investors are advised to consider other financial metrics and qualitative analysis alongside the P/E ratio for informed investment decisions.

**2. Invesco Unlocks $180 Million Windfall After QQQ Vote Passes**
- Source: Bloomberg.com | 20251219T141529 | Bullish | Relevance: 100%
- Invesco Ltd. is set to gain an estimated $180 million in annual revenue after shareholders of its $402 billion QQQ Trust Series 1 voted to convert the fund into an open-ended structure. This change moves the fund away from its older unit investment trust structure, enabling the asset manager to potentially earn more by lending out the securities. This strategic shift modernizes the fund's operations and financial benefits.

**3. Invesco QQQ Shareholders Vote to Approve Modernization**
- Source: PR Newswire | 20251219T135523 | Bullish | Relevance: 100%
- Invesco QQQ shareholders have approved a modernization plan, restructuring the fund from a unit investment trust ETF to an open-end fund ETF and changing its governance to a board of trustees. This change, expected to take effect on Monday, December 22, will reduce the fund's total expense ratio from 0.20% to 0.18%, offering a 10% fee reduction for investors while providing greater flexibility for reinvesting income and participating in securities lending without tax implications for shareholders. The modernized QQQ ETF will continue to track the Nasdaq-100 IndexÂ® and remain a key component of Invesco's QQQ Innovation Suite.

**4. Invesco Small Cap Growth Fund Q3 2025 Commentary (Mutual Fund:GTSVX)**
- Source: Seeking Alpha | 20251218T231734 | Neutral | Relevance: 100%
- The Invesco Small Cap Growth Fund underperformed its benchmark in Q3 2025 despite small-cap stocks having their best quarterly return since 2021, primarily due to stock selection in the healthcare, IT, and consumer discretionary sectors. The fund is optimistic about long-term prospects, citing AI capital spending, AI-led productivity gains, and potential lower interest rates. The investment strategy is leaning towards cyclical positioning in anticipation of Fed rate cuts and tariff relief, with new holdings reflecting conviction in semiconductor capex, institutional crypto, utility software, and clean power.

**5. February 2026 Options Now Available For Invesco (IVZ)**
- Source: Nasdaq | 20251218T171323 | Somewhat-Bullish | Relevance: 100%
- New options contracts for Invesco Ltd (IVZ) with a February 2026 expiration are now available. BNK Invest's YieldBoost formula highlights a put contract at a $24.00 strike price and a call contract at a $27.00 strike price as potentially attractive for investors looking to either buy IVZ at a discount or generate additional income through covered calls. The article details the potential returns and risks associated with these specific options strategies.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 4, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $28 | $27 | +4% |
| 2025-12-17 | Deutsche Bank | $31 | $26 | +19% |
| 2025-12-12 | Barclays | $28 | $25 | +12% |
| 2025-12-10 | BMO Capital | $30 | $28 | +7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | main | Equal-Weight |
| 2025-12-17 | Deutsche Bank | up | Buy |
| 2025-12-12 | Barclays | main | Equal-Weight |
| 2025-12-10 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 5 ($2.51M) |
| Sells | 5 ($4.56M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 60.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Massachusetts Mutual: 18.3% (0.0%)
- Vanguard Group Inc: 11.7% (+1.1%)
- Blackrock Inc.: 8.5% (-16.7%)
- State Street Corpora: 4.8% (-3.3%)
- Dimensional Fund Adv: 4.8% (+1.5%)

### Key Risks

1. Insider selling cluster: $4.6M in recent transactions.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +11%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.48 indicates undervaluation relative to growth. Forward P/E 10.7x attractive for 27% earnings growth. Quality metrics strong (margin 17%). Analyst sentiment positive (4 raises, avg +11%). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.0B |
| Beta | 1.64 |
| 52W Range | $11.60 - $27.31 |
| Short Interest | 5.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.48 |
| Forward P/E | 10.7 |
| Current P/E | 13.7 |
| YoY Growth | 27.1% |
| EPS Direction | RISING |

### Technicals

MRS_10 stable at 1.9% (minimal 5-day change). Below STRENGTH zone by 1.1pp (needs >3.0% for momentum thesis). MRS_5 at 1.1% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.93% (CS: 84) | Neutral |
| RSI_14 | 67.6 | Neutral |
| MACD Histogram | 0.06 | Bullish |
| vs SMA20 | 1.060x | Above |
| vs SMA50 | 1.117x | Above |
| vs SMA200 | 1.401x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $27.00
- **Stop Loss:** $25.44 (5.8% risk)
- **Target:** $28.56 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 576
- **Position Value:** $15,552.00
- **Portfolio %:** 15.55%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-01-27 (Est: $0.57)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.44 | $0.61 | +37.7% |
| 2025Q2 | $0.40 | $0.36 | -10.7% |
| 2025Q1 | $0.39 | $0.44 | +13.9% |
| 2024Q4 | $0.47 | $0.52 | +9.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*